Position in IQV
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$5,305,627
+$1,007,167 QoQ
Shares Held
27,459
+8.9% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#302
of 1,077 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Rakuten Investment Management, Inc. holds $82,930,368 across 8 Diagnostics & Research names. IQV ranks #6 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
60,839 | $30,502,241 | |
| 2 | DHR |
Danaher Corp /De/
|
103,733 | $19,759,061 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
19,036 | $10,021,311 | |
| 4 | A |
Agilent Technologies, Inc.
|
46,470 | $6,172,610 | |
| 5 | WAT |
Waters Corp /De/
|
16,068 | $6,026,142 | |
| 6 | IQV |
Iqvia Holdings Inc.
This page
|
27,459 | $5,305,627 | |
| 7 | DGX |
Quest Diagnostics Inc
|
18,058 | $3,827,393 | |
| 8 | RVTY |
Revvity, Inc.
|
11,828 | $1,315,983 |
All Filings in IQV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,305,627 | 27,459 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $4,298,460 | 25,205 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,046,929 | 22,390 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,869,087 | 109,872 | Shares | Sole | 2025-10-30 | |
| 2025-03-31 | $2,764,912 | 15,683 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $2,364,486 | 9,978 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $1,639,717 | 7,755 | Shares | Sole | 2025-05-15 | |
| 2024-03-31 | $1,240,931 | 4,907 | Shares | Sole | 2025-05-15 | |
| 2023-12-31 | $104,583 | 452 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||